# Efficacy and Safety of Oral Herbal Medicine Combined with Diosmectite for Pediatric Rotavirus Gastroenteritis: A Systematic Review and Meta-Analysis

**Authors:** Jung-Hyun Cho, Eun-Jin Kim, Hyun-Kyung Sung, Sang-Yeon Min

PMC · DOI: 10.3390/healthcare14060711 · Healthcare · 2026-03-11

## TL;DR

This study evaluates if combining herbal medicine with diosmectite improves treatment outcomes for children with rotavirus gastroenteritis.

## Contribution

The study provides a systematic review and meta-analysis of herbal medicine combined with diosmectite for pediatric rotavirus gastroenteritis.

## Key findings

- Combined treatment reduced diarrhea duration and hospital stay.
- It improved total effective rate and reduced adverse events.
- Evidence certainty ranged from moderate to very low.

## Abstract

Background/Objectives: Rotavirus is a leading cause of severe acute gastroenteritis in children and is commonly associated with prolonged diarrhea and dehydration. Herbal medicine (HM) is frequently used in combination with diosmectite in clinical practice, but the effectiveness of this combined approach has not been systematically evaluated. This study aimed to assess the efficacy and safety of HM combined with diosmectite in pediatric rotavirus gastroenteritis. Methods: We searched 12 databases from inception to 10 December 2025. Randomized controlled trials comparing HM plus diosmectite with diosmectite alone in children with rotavirus gastroenteritis were included. Study selection, data extraction, and risk-of-bias assessment were independently performed by two researchers. Meta-analyses were conducted using RevMan 5.4, and the certainty of evidence was evaluated with GRADEpro. Results: A total of 26 RCTs involving 2876 children were included. Compared with diosmectite alone, HM combined with diosmectite significantly reduced the duration of diarrhea (SMD −1.31; 95% CI −1.63 to −0.99), improved the total effective rate (RR 1.25; 95% CI 1.19 to 1.31), decreased the incidence of adverse events (RR 0.24; 95% CI 0.06 to 0.92), and a shorter length of hospital stay (MD −1.53; 95% CI −1.73 to −1.33). The certainty of evidence ranged from moderate to very low. Conclusions: HM combined with diosmectite may offer a potential adjunctive therapy for pediatric rotavirus gastroenteritis. However, more robust and high-quality evidence is required to further substantiate its efficacy and safety.

## Linked entities

- **Chemicals:** diosmectite (PubChem CID 71586775)

## Full-text entities

- **Diseases:** diarrhea (MESH:D003967), gastroenteritis (MESH:D005759), dehydration (MESH:D003681), Rotavirus (MESH:D012400)
- **Chemicals:** Oral Herbal Medicine (-), Diosmectite (MESH:C033214)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026062/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026062/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026062/full.md

---
Source: https://tomesphere.com/paper/PMC13026062